Selmi et al. 2020 (PRJNA591625)
General Details
| Title | Sequence- and structure-specific cytosine-5 methylation in mRNAs by NSUN6 |
|---|---|
| Organism | |
| Number of Samples | 38 |
| Release Date | 2019/11/25 00:00 |
| Sequencing Types | |
| Protocol Details |
Study Links
| GWIPS-viz | Trips-Viz |
|---|---|
Repository Details
| SRA | SRP233222 |
|---|---|
| ENA | SRP233222 |
| GEO | GSE140997 |
| BioProject | PRJNA591625 |
Publication
| Title | |
|---|---|
| Authors | Selmi T, Hussain S, Dietmann S, Heiß M, Borland K, Flad S, Carter JM, Dennison R, Huang YL, Kellner S, Bornelöv S, Frye M |
| Journal | Nucleic acids research |
| Publication Date | 2021 Jan 25 |
| Abstract | The highly abundant N6-methyladenosine (m6A) RNA modification affects most aspects of mRNA function, yet the precise function of the rarer 5-methylcytidine (m5C) remains largely unknown. Here, we map m5C in the human transcriptome using methylation-dependent individual-nucleotide resolution cross-linking and immunoprecipitation (miCLIP) combined with RNA bisulfite sequencing. We identify NSUN6 as a methyltransferase with strong substrate specificity towards mRNA. NSUN6 primarily targeted three prime untranslated regions (3'UTR) at the consensus sequence motif CTCCA, located in loops of hairpin structures. Knockout and rescue experiments revealed enhanced mRNA and translation levels when NSUN6-targeted mRNAs were methylated. Ribosome profiling further demonstrated that NSUN6-specific methylation correlated with translation termination. While NSUN6 was dispensable for mouse embryonic development, it was down-regulated in human tumours and high expression of NSUN6 indicated better patient outcome of certain cancer types. In summary, our study identifies NSUN6 as a methyltransferase targeting mRNA, potentially as part of a quality control mechanism involved in translation termination fidelity. © The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. |
| PMC | PMC7826283 |
| PMID | 33330931 |
| DOI |
| Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SRR10530116 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide |  |
 |
 |
 |
|
|
||
| SRR10530117 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530118 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530119 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530120 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530121 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530122 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530123 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530124 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530125 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530126 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530127 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530128 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530129 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530130 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530131 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530132 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530133 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530134 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530135 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530136 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530137 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530138 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530139 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530140 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530141 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530142 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530143 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530144 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530145 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530146 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530147 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530148 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530149 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530150 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530151 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530152 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| SRR10530153 | PRJNA591625 | Homo sapiens | H9 | Ribo-Seq | Cycloheximide | |
|
|
|
|
|
||
| Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About